相关实验视频
Updated: May 2, 2026

08:11
Quantitative Analysis of Chromatin Proteomes in Disease
Published on: December 28, 2012
13.1K
解读心力衰竭:一种集成的蛋白质和转录基因方法,具有实验验证
Jun Cao1, Zhaohai Su1, Bilong Zhang1
1Department of Cardiology, Ganzhou Hospital of Guangdong Provincial People's Hospital, Ganzhou Municipal Hospital (Gannan Medical University Affiliated Municipal Hospital), 49 Dagong Road, 341000, Ganzhou, China.
Functional & integrative genomics
|October 23, 2024
概括
心力衰竭 (HF) 涉及到分子变化,特别是增加的长链酶家族成员4 (ACSL4) 的乙烯基-CoA合成酶. 准ACSL4以抑制铁灭症显示出作为HF的新治疗策略的希望.
科学领域:
- 心血管生物学 心血管生物学
- 分子医学是分子医学.
- 生物化学 生化学
背景情况:
- 心力衰竭 (HF) 是一种复杂的综合征,其特点是显著的分子变化.
- 铁亡是一种受调节的细胞死亡形式,越来越多地被认为是其在心血管疾病发病过程中的作用.
研究的目的:
- 用多omics数据识别心力衰竭中的关键分子变化.
- 为了研究向铁亡的治疗潜力,特别是HF中的蛋白质ACSL4,HF.
主要方法:
- 来自人类HF样本和HF小鼠模型的转录和蛋白质组数据的分析.
- 不同表达基因 (DEG) 和蛋白质的交叉分析.
- 使用低氧诱导性缺血病模型在HL-1心肌细胞中进行功能验证,并进行ACSL4敲击.
主要成果:
- 多omics分析显示,HF中免疫,炎症和代谢途径的显著丰富.
- 在高频率中,ACSL4的表达在转录和蛋白质水平上都得到了持续的上调.
- 在体外,ACSL4敲击抑制了铁亡,减少了氧化应激标志物 (ROS,MDA,自由铁),并改善了心肌细胞活力.
结论:
- 增加ACSL4表达是心力衰竭的一个关键分子事件.
- 准ACSL4以抑制铁亡是一种潜在的新疗法策略,用于治疗心力衰竭.
相关概念视频
Pathophysiology of Heart Failure
4.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.8K
Heart Failure I: Introduction
1.7K
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.7K
Heart Failure II: Pathophysiology
1.9K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.9K
Heart Failure IV: Classification and Diagnostic Evaluation
1.0K
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
1.0K
Cardiomyopathy II: Dilated Cardiomyopathy
790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790

